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ABSTRACT
ORP3 is a member of the newly described family of oxysterol-binding protein (OSBP)-related proteins (ORPs).
We previously demonstrated that this gene is highly expressed in CD341 hematopoietic progenitor cells, and
deduced that the “full-length” ORP3 gene comprises 23 exons and encodes a predicted protein of 887 amino
acids with a C-terminal OSBP domain and an N-terminal pleckstrin homology domain. To further charac-
terize the gene, we cloned ORP3 cDNA from PCR products and identified multiple splice variants. A total of
eight isoforms were demonstrated with alternative splicing of exons 9, 12, and 15. Isoforms with an extension
to exon 15 truncate the OSBP domain of the predicted protein sequence. In human tissues there was specific
isoform distribution, with most tissues expressing varied levels of isoforms with the complete OSBP domain;
while only whole brain, kidney, spleen, thymus, and thyroid expressed high levels of the isoforms associated
with the truncated OSBP domain. Interestingly, the expression in cerebellum, heart, and liver of most iso-
forms was negligible. These data suggest that differential mRNA splicing may have resulted in functionally
distinct forms of the ORP3 gene.
1
INTRODUCTION
ORPs (OXYSTEROL-BINDING PROTEIN (OSBP)-related pro-teins) are a family of closely related gene sequences with
two major structural features: a highly conserved oxysterol-
binding domain present in the C-terminal region, and, in most
cases, an N-terminal pleckstrin homology (PH) domain. Twelve
human ORPs or OSBPLs (oxysterol binding protein-like), all
containing the eight amino acid oxysterol-binding signature,
have now been described (Jaworski et al., 2001; Lehto et al.,
2001), although the function of most of these proteins has not
been investigated. Early studies (Kandutsch and Thompson,
1980) identified the first ORP (designated OSBP) and showed
that it is a cytosolic protein with a high affinity for the oxy-
sterol, 25-hydroxycholesterol (25-OHC) (Dawson et al., 1989).
Further studies determined that with ligand (25-OHC) binding,
OSBP translocates and binds extrinsically to the Golgi mem-
branes (Ridgway et al., 1992). This action is mediated by the
PH domain (Lagace et al., 1997; Levine and Munro, 1998), and
involves interaction with VAMP-associated protein-A (Wyles
et al., 2002). It is speculated that the OSBP translocation and
binding plays a role in the transport, metabolism, or regulatory
action of lipid factors and oxysterols (Lagace et al., 1997;
Levine and Munro, 1998). Oxysterols are oxygenated deriva-
tives of cholesterol, which enter the cell from the circulation
via the low density lipoprotein (LDL) receptor or can be syn-
thesised de novo. Their binding to OSBP has been well char-
acterized, and their biologic actions include inhibition of cel-
lular proliferation and induction of apoptosis (Brown and
Jessup, 1999). Recently, we have shown that oxysterols are po-
tent inhibitors of proliferation of hematopoietic cells (Grego-
rio-King et al., 2002). It has been postulated that all members
of the ORP family have a role in the binding of oxysterols or
other lipid moieties, and therefore, may play a role in the trans-
duction of the cellular effects (Lagace et al., 1997).
Of the related proteins, ORP1 and ORP2 were found to bind
phospholipids but not 25-OHC (Xu et al., 2001). Further char-
acterization implicated ORP2 as a regulator of cellular sterol
homeostasis and intracellular membrane trafficking (Laitinen et
al., 2002). Full-length ORP4 (ORP4-L) and a related splice vari-
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ant (ORP4-S) were overexpressed in CHO cells (Wang et al.,
2002) and experiments showed that ORP4-L bound 25-OHC
with high affinity. The splice variant, in which the PH domain
and part of the OSBP domain were deleted, did not bind oxys-
terols but interacted with the cytoskeletal network of vimentin
intermediate filaments. In addition, cells overexpressing ORP4-
S had a 40% reduction in the esterification of LDL-derived cho-
lesterol, implying that interaction with the vimentin network
modifies cholesterol transport.
Although normal tissues appear to express all ORPs, there
are tissue-specific differences (Jaworski et al., 2001; Lehto et
al., 2001). In general, the brain and kidney express the highest
levels of the various ORPs, and this has been postulated to be
due to the active membrane transport processes in these tissues
(Laitinen et al., 1999). The ORPs have been classified into six
separate subfamilies according to sequence similarity and
shared protein features. It is interesting to note that ORPs within
a subfamily, although similar in genomic structure, have var-
ied tissue patterns (Lehto et al., 2001). ORP4 (designated the
HeLa metastatic gene) was found to be differentially expressed
in metastatic tumour cells (Fournier et al., 1999). In addition,
ORP4 mRNA levels have been indicated as a potential marker
for hematologic malignancies (Silva et al., 2001), while other
studies demonstrate high expression of ORP4 in retina, testis,
and fetal liver (Moreira et al., 2001). A recent study (Lehto et
al., 2001) investigated whether the expression of human ORPs
is influenced by changes in the cellular cholesterol status, and
showed that ORP6 was the only gene upregulated in acidified
LDL-loaded macrophages.
In a previous study we identified the ORP3 gene, and found
that it is more highly expressed in CD34 positive (CD341) com-
pared with CD34 negative hematopoietic cells (CD342) (Gre-
gorio-King et al., 2001). We deduced the complete ORP3 gene
from RACE, EST sequences, and homology to genomic clones,
to give the “full-length” ORP3, comprising 23 exons and en-
coding a protein containing 887 amino acids (Accession No:
AY008372). ORP3 displays the characteristic PH and OSBP
domains, and like some other ORPs, a putative leucine zipper
and dimerisation region. The size and distribution of the ORP3
exons is very similar to ORP6 and ORP7, and therefore, they
have been grouped into one of the ORP subfamilies (subfam-
ily III) (Lehto et al., 2001). In addition to hematopoietic cells,
ORP family studies have demonstrated ORP3 expression in
spleen and leukocytes (Laitinen et al., 1999), kidney and thy-
mus (Lehto et al., 2001).
Studies focussing on the human ORP gene family, com-
bined with evidence from the NCBI databases, indicate that
there are a number of examples of alternative splicing (Ja-
worski et al., 2001; Lehto et al., 2001); however, there are
few specific examples. A recent study (Wang et al., 2002),
identified a shortened form of ORP4 that encoded an alter-
native exon between exons 2 and 3, resulting in deletion of
the PH domain and part of the oxysterol-binding domain.
Western blot analysis of ORP2 in mouse tissues also revealed
two major immunoreactive forms; possibly representing
translated variants (Laitinen et al., 2002). Further investiga-
tion of the ORP3 gene by our laboratory revealed a large num-
ber of previously undescribed splice variants. In this study
we identify these isoforms and investigate their expression in
various tissues.
MATERIALS AND METHODS
Preparation of hematopoietic mononuclear cells and
cord blood CD341 samples
Umbilical cord blood samples (UCB) were obtained after un-
complicated vaginal or cesarean delivery with clamping and
cutting of the cord and drainage into sterile collection tubes.
All samples were donated by volunteers according to approved
institutional guidelines. Mononuclear cells (MNC) were pre-
pared by density gradient separation through Ficoll-Hypaque
(Amersham Pharmacia Biotech, Uppsala, Sweden). CD341
cells were isolated immunomagnetically by positive selection
using antibody labelling and a MiniMacs™ bead separation kit
following the manufacturers instructions (Miltenyi Biotec, Bec-
ton Dickinson, Fullerton, CA). Viability was assessed using
Trypan Blue staining and purity of CD341 populations was de-
termined by flow cytometric analysis (FacsCalibur, Becton
Dickinson). CD341 samples of greater than 70% purity were
used for RNA extraction.
Total RNA isolation and reverse transcription
Total RNA from MNC and CD341 and CD342 samples were
extracted using Trizol (Invitrogen, San Diego, CA) according
to the manufacturer’s instructions. A human RNA tissue panel
was purchased from Clontech (Palo Alto, CA). Prior to cDNA
synthesis all samples were DNase (Promega, Madison, WI)
treated to remove any contaminating genomic DNA. One mi-
crogram of DNA-free RNA was reverse transcribed using ran-
dom hexamers in the Reverse Transcription System (Promega,
Madison, WI) according to the manufacturer’s guidelines. All
reactions were performed on a Perkin-Elmer (Norwalk, CT)
9600 thermocycler. cDNA from eight CD341 and CD342
samples were pooled respectively and used in subsequent PCR
reactions.
PCR and cloning
Primers were designed (using Primer Express software) to
amplify the full coding region of ORP3 (Table 1), and PCR car-
ried out using MNC samples and a liver cDNA library (gener-
ously supplied by Professor GR Collier, Deakin University)
with Platinum Taq polymerase (Invitrogen) and touchdown cy-
cling (61°C reducing to 58°C) for 44 cycles. Amplified prod-
ucts were visualized by standard agarose gel electrophoresis and
ethidium bromide staining. Bands of the correct size were ex-
cised from the gel, purified (Clontech Nucleo-Trap), and cloned
using PCRscript (Clontech) or TOPO-TA (Invitrogen) cloning
kits. Colonies were picked, restriction enzyme digests per-
formed to confirm inserts, plasmid DNA prepared (Eppendorf
Perfectprep), and the inserts sequenced using an ABI Prism™
373 DNA Sequencer (P.E. Applied Biosystems, Foster City,
CA) and vector primers.
Semiquantitative PCR
Investigation of splice variants was performed on a selection
of human tissue cDNA samples (bone marrow, cerebellum, to-
tal brain, heart, kidney, liver, lung, skeletal muscle, spleen, thy-
mus, thyroid, and colon) and pooled UCB CD341 and CD342
cDNA. Specific primers (Primer Express®, PE Applied Biosys-
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tems) were designed to amplify GAPDH mRNA, and two re-
gions of the ORP3 mRNA. Primer set 1 (Table 1) amplified a
region from within exon 8 to the exon 15/16 border, while
primer set 2 (Table 1) spanned a region from within exon 8 to
an extended region of exon 15 in the ORP3 gene. PCR reac-
tions were performed using Platinum Taq polymerase (Invitro-
gen), standard conditions and 39 cycles (ORP3, primer set 1
and 2) or 28 cycles (GAPDH).
For both of the ORP3 primer sets, four products were am-
plified representing the various isoforms, although only three
bands were easily distinguishable. The products were desig-
nated A, B, C, and D for each primer set, and each of the prod-
ucts was confirmed by either restriction enzyme digest, or a
subsequent nested PCR (see below), and sequencing (as de-
scribed above). As PCR products B and C were seen as one
band that differed in size by only 15 base pairs, a post-PCR re-
striction enzyme digest (Nde 1) was performed in an effort to
further separate the bands (Primer set 1 only). This resulted in
truncation of all the amplicons and bands that were more eas-
ily identified on the gel.
To further investigate PCR products B and C, nested PCR
reactions were performed to separately amplify each isoform.
The initial PCR reaction (primer set 1 and 2) was reperformed
for 20 cycles on the panel of cDNA, the product diluted 1:2
and used in a secondary reaction with primers for the specific
isoforms (primer set 3 and 4; Table 1). PCR reactions were per-
formed using Platinum Taq polymerase (Invitrogen), standard
conditions and 21 cycles.
All PCR products were visualized by 2% agarose gel elec-
trophoresis and ethidium bromide staining, and the relative band
intensities for all PCR reactions evaluated using the Kodak
EDAS system and semiquantified relative to GAPDH. Each
PCR reaction was repeated in triplicate.
Bioinformatics
Nucleic acid and protein sequences were analyzed using soft-
ware available from the National Center for Biotechnology In-
formation (NCBI) and Swiss Institute of Bioinformatics (SIB)
databases. Alignment of splice variant sequences was per-
formed using Bioedit.
RESULTS
Identification of ORP3 isoforms
PCR was utilised to amplify the full coding region of ORP3
(Accession number, AY008372). The PCR product from the
MNC resulted in a band at the expected size (2815 nucleotides),
while the product derived from the liver library was approxi-
mately 400 nucleotides larger (Fig. 1). Both products were lig-
ated into “housekeeping” vectors and the colonies picked re-
vealed a number of different ORP3 splice variants. BLAST
searches on the NCBI database indicated that the PCR product
from MNC resulted in four isoforms with variations in the in-
clusion or exclusion of exons 9 and/or 12 (Fig 2i). The prod-
ucts from the liver cDNA library included variants with a larger
exon 15, as well as inclusion/exclusion of exon 9. In these cases,
the new extended exon 15 was 399 base pairs longer than pre-
viously shown, with additional sequence matching to the ge-
nomic clone (Accession number, AC004016) and previously re-
garded as postexon 15 intronic. Further investigation of other
tissues by PCR revealed that all exon 9/12 variations were also
expressed by the extended isoform 15 (Fig. 2ii). The other ex-
ons in the clones were identical to the “full-length” ORP3.
To clarify the nomenclature, the eight isoforms were desig-
nated ORP3 (1a–1d)5 all isoforms with “standard exon 15”
(Accession No: AF491781–AF491784), or ORP3 (2a–2d)5
all isoforms with “extended exon 15” (Accession No:
AF491785–86 and AF515639–40) (Fig. 2i and ii). Therefore
“full-length” ORP3 (1a) is equivalent to the standard exon 15
variant which includes both exon 9 and 12 (Fig. 2i).
Conceptual translations of ORP3 isoforms
Translation of “full-length” ORP3 isoform (1a) is initiated
by a start codon in exon 2, extends for 2664 nucleotides, and
terminates in exon 23. ORP3 isoforms (1b–1d) skip exons 9
and/or 12, which have lengths of 93 nucleotides and 108 nu-
cleotides, respectively. These deletions shorten the ORP3 pro-
tein by 31 amino acids and 36 amino acids, respectively, but
stay in frame, do not modify the PH or OSBP domains, or cause
a premature stop (Fig. 3).
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TABLE 1. SEQUENCES OF PRIMER PAIRS
Name Forward (59-39) primer Reverse (59-39) primer
Full coding region ORP3 TGGATAAGAGCTAAACCACCTG AGGCAAGCACAGGAGAAATACAC
GAPDH CAGTCAGCCGCATCTTCTTTTG TGGTTCACACCCATGACGAAC
ORP3 primer set 1 GCATCGGACATACTCGGCAC GCTGCCACATATACCATCCTTTCC
ORP3 primer set 2 GCATCGGACATACTCGGCAC CCAGACAGCTCTGAGTAATG
ORP3 primer set 3 CAACGCCATCCAGGTCCCGAAAC CATGGATTCTGCGTAAGCGTTC
ORP3 primer set 4 CCAGAGCTATTGGCAAAGATG CTGGAGTTTTCGGATGACAGG
FIG. 1. PCR amplification of the full coding region of ORP3
for cloning. Lanes (from left) are molecular size ladder, human
liver library cDNA (Clontech), and reverse transcribed MNC
cDNA.
In contrast, conceptual translation of the extended exon
15 isoforms (ORP3 (2a–2d)), alters the reading frame 96
amino acids into the OSBP domain, and results in an addi-
tional 59 amino acids of novel sequence before the transla-
tion terminates. The majority of the oxysterol-binding do-
main and the OSBP signature are omitted and the novel
sequence does not contain any conserved motifs or protein
patterns. Similar deletions of exon 9 and/or 12 occur in the
extended exon 15 isoforms (Fig. 3). None of the exon vari-
ations (exons 9, 12, or 15) identified here alter the putative
dimerization box or leucine zipper region (Gregorio-King et
al., 2001).
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FIG. 2. Splice variants of ORP3 and position of specific primer pairs. Schematic diagram of exon 8 to exon 16 of the ORP3
coding region displaying areas of alternative splicing and the various isoforms for the standard exon 15, ORP3 (1a–1d), (i) and
extended exon 15, ORP3 (2a–2d), (ii). The shaded boxes denote the exons, with the alternatively spliced exons represented by
open boxes. The primer pairs for ORP3 isoform detection are marked and shown as a thick line. If they span an exon–exon
boundary they are joined by a curved line.
ii
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Semiquantitative PCR
To evaluate the respective amounts of the various isoforms
in a selection of tissue samples, PCR reactions were performed
using specific primer sets (Fig. 2i and ii) for the ORP3 isoforms
and semiquantitated relative to GAPDH mRNA expression.
Due to the common characteristics of the isoforms, RT-PCR
was determined to be the only way to investigate the distribu-
tion of all eight isoforms.
The standard exon 15 isoforms, ORP3 (1a–1d), were highly
expressed in brain, kidney, spleen, thymus, thyroid, colon, and
cord blood CD341 and CD342 hematopoietic cells. Interest-
ingly, in contrast to the whole brain, the level of mRNA ex-
pression in cerebellum was very low (Fig. 4, Graph i, lane 2).
ORP3 (1a) mRNA was the most common isoform with ex-
pression in kidney, whole brain, thyroid, and skeletal muscle,
but with no demonstrable expression in heart and liver. With
the exception of CD342 hematopoietic cells, expression of
ORP3 (1d) was low, with no expression observed in brain and
cerebellum (Fig. 4, graph i).
To further investigate ORP3 (1b) and (1c) (exon 9-less and
exon 12-less) isoforms, nested PCR reactions were performed
with primer pairs specific for the variants (primer set 3 and 4,
Fig. 2). As with ORP3 (1a), expression of ORP3 (1b) and (1c)
was demonstrated in all tissues except heart and liver. Expres-
sion of ORP3 (1c) was highest in total brain, kidney, lung, skele-
tal muscle, thyroid, and cord blood CD341 and CD342 cells.
Colon was the only tissue with higher expression of ORP3 (1b)
than (1c) (Fig. 4, graph ii).
The extended exon 15 isoforms (ORP3 2a–2d), which re-
sult in a truncation of the OSBP region, were expressed in
most tissues except cerebellum, heart, liver, and lung; with
the highest expression in whole brain, kidney, spleen, thy-
mus, thyroid, and CD341 cells. Expression of ORP3 (2a) was
generally greater than ORP3 (2b), (2c), or (2d). The ORP3
(2d) isoform was expressed in spleen, thymus, colon, and
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FIG. 3. Diagrammatic representation of conceptual proteins for ORP3 (1a–1d) and (2a–2d) isoforms. The number of amino acids
indicates the predicted size. Group (i): predicted proteins for standard exon 15 isoform, ORP3 (1a–1d). Group (ii): predicted pro-
teins for extended exon 15 isoforms, ORP3 (2a–2d). The pleckstrin homology (PH) and OSBP domains are labeled and shaded. The
highly conserved sequence motif “EQVSHHPP” is marked in the OSBP region. In ORP3 (2a–2d) the OSBP domain is truncated,
the motif EQVSHHPP deleted, and there is an area of novel sequence, marked by crosshatching.
CD341 and CD342 cells, but at fairly low levels in compar-
ison to the other isoforms. The nested PCR reactions for the
separate identification of the ORP3 (2b) and (2c) isoforms
revealed expression in all the tissues as predicted from the
original PCR. There was far greater expression of ORP3 (2c)
than (2b) in the total brain and skeletal muscle; with the re-
verse seen in thymus bone marrow and CD341 cells. All four
extended exon 15 isoforms (ORP3 2a–2d) had very low
mRNA expression in CD342 cells (Fig. 5).
DISCUSSION
It has been estimated that, based on analyses of EST, the
transcripts from 35% of human genes are alternatively spliced
(Graveley, 2001) and recent studies indicate there is ample ev-
idence for multiple splicing in the ORP family (Jaworski et al.,
2001; Lehto et al., 2001). We have demonstrated eight splice
variants of the ORP3 gene with specific tissue distributions.
The alternative splicing of the isoforms includes exon “skip-
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FIG. 4. Semiquantitative RT-PCR analysis of (ORP3 (1a–1d)) in bone marrow (1), cerebellum (2), whole brain (3), heart (4),
kidney (5), liver (6), lung (7), skeletal muscle (8), spleen (9), thymus (10), thyroid (11), colon (12), cord blood CD341 (13), cord
blood CD342 (14), and no template control (15). The far left lane contains the DNA ladder. The numbers below graph (ii) rep-
resent the same tissues. (A) PCR analysis of ORP3 (1a–1d) using Primer set 1, with post-PCR Not1 enzyme digest. (B) Nested
PCR analysis of ORP3 (1b) using Primer set 3. (C) Nested PCR analysis of ORP3 (1c) using Primer set 4. (D) PCR analysis of
GAPDH. Gene expression of the various isoforms was measured by the Kodak EDAS system and quantitated relative to GAPDH.
Graph (i): Relative intensities of ORP3 isoforms in gel image (A). Graph (ii): Relative intensities of ORP isoforms in gel im-
ages (B) and (C).
ping” and exon “elongation” at the 59 splice site. The extension
to exon 15 is confirmed by a number of sequences from 
the EST database (Accession Nos: BF771076, BF770483,
BI771299, BF771055, BF770475, AW798464); while the skip-
ping of exon 9 and/or 12 do not appear to be currently repre-
sented. However, a mouse clone (Accession No: AK004768),
with significant homology to ORP3, exhibits the deletion of the
equivalent of human ORP3 exon 9. As ORP3, ORP 6, and ORP7
make up ORP subfamily III (Lehto et al., 2001), and their ex-
ons 9, 12, and 15 are almost identical in size, it is possible that
the same splice variations demonstrated in ORP3 may occur in
ORP6 and ORP7. In the current study, aside from the eight iso-
forms described here, we have identified further splice varia-
tions at the start of exon 3 (deletion of five base pairs) and exon
11 (deletion of 16 base pairs), respectively (data not shown).
The nucleotides at these alternate sites exhibit a conserved 39
splice site sequences (Shapiro and Senapathy, 1987).
In the standard exon 15 isoforms (ORP3 (1a–1d)) the alter-
native splicing of exon 9 and/or 12 shortens the translated pro-
tein but keeps both the OSBP and PH domains intact. As these
domains are implicated in oxysterol and phospholipid binding
and translocation to the Golgi apparatus, respectively, these iso-
forms would presumably retain the functional characteristics of
OSBP. The deletion of exon 9 (31 amino acids) would result
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FIG. 5. Semiquantitative RT-PCR analysis of ORP3 (2a–2d) in bone marrow (1), cerebellum (2), whole brain (3), heart (4),
kidney (5), liver (6), lung (7), skeletal muscle (8), spleen (9), thymus (10), thyroid (11), colon (12), cord blood CD341 (13), cord
blood CD342 (14), and no template control (15). The far left lane contains the DNA ladder. The numbers below graph (ii) rep-
resent the same tissues. (A) PCR analysis of ORP3 (2a–2d) using Primer set 2. (B) Nested PCR analysis of ORP3 (2b) using
Primer set 3. (C) Nested PCR analysis of ORP3 (2c) using Primer set 4. (D) PCR analysis of GAPDH. Gene expression of the
various isoforms was measured by the Kodak EDAS system and quantitated relative to GAPDH. Graph (i): Relative intensities
of ORP3 isoforms in gel image (A). Graph (ii): Relative intensities of ORP isoforms in gel images (B) and (C).
in the loss of two PKC phosphorylation sites while exon 12 (36
amino acids) has no commonly recognised patterns. The ex-
tension of exon 15 [ORP3 (2a–2d)] results in a shift in the read-
ing frame, the loss of the majority of the oxysterol-binding do-
main and additional 59 amino acids of novel sequence. Expasy
software indicates that this additional sequence displays no cur-
rently described domains or motifs. It is, therefore, difficult to
predict the function, if any, of these splice variants. However,
the truncated ORP3 isoforms are comparable to mutant versions
of OSBP, which lack all or part of the oxysterol-binding do-
main (Ridgway et al., 1992). The mutants were expressed in
CHO or COS cells, and although oxysterols binding was not
detected, they localized spontaneously to the Golgi apparatus.
This was in contrast to the “wild-type” OSBP that translocated
to the Golgi only when the oxysterol ligand binds. This study
demonstrated that the oxysterol-binding site is in the COOH-
terminal half of the protein, and it was suggested that this area
of the protein exerts a tonic inhibitory effect upon Golgi local-
isation (Ridgway et al., 1992). A more recent study utilised a
yeast two-hydrid screen to identify a binding partner for OSBP;
VAMP-associated protein-A (VAPA), a syntaxin-like protein
implicated in ER/Golgi vesicle transport. The VAP-A binding
region in OSBP was localized to the N-terminus of the OSBP
domain and further mutant experiments indicated that intact
oxysterol binding was not necessary for VAP-A binding. Both
the full-length and truncated ORP3 splice variants contain this
binding area. In vitro overexpression studies of the two ORP3
isoforms, (1a) and (2a), will determine if the truncated ORP3
behaves as a possible regulator of the “full-length” ORP3 by
blocking Golgi translocation, and whether the splice variants
behave in a similar way to the OSBP mutants. Other ORP splice
variants have been described for ORP4 (ORP4-S) (Wang et al.,
2002) and ORP1 (OSBPL1a) (Jaworski et al., 2001), but in
these cases the PH domain was deleted and the major part of
the OSBP region intact. As this is the opposite of the ORP3
isoform truncation, the actions of ORP4 cannot be compared
with our predicted proteins.
Our previous study confirmed the size of the “full-length”
ORP3 by northern blot analysis (approx 7.0 kb) and demon-
strated two other transcripts (approx 3.6 and 4.4 kb) (Gregorio-
King et al., 2001). The probe used in this study was specific
for “standard exon 15” isoforms, and we are unable to ascer-
tain whether these smaller transcripts relate to any of the iso-
forms ORP3 (1a–1d); which were amplified from the coding
region only and therefore do not include the long 39 sequence.
It is more likely, however, that the variations observed in the
northern blot are a consequence of large variations in the non-
coding region, as seen in an ORP3 clone from a uterine
leiomyosarcoma (Genbank Accession No. BC017731), in
which the ORP3 (1a) sequence is conserved but the 39 un-
translated region is shortened by approximately 3.4 kb.
The mRNA expression of each isoform varied considerably
between tissues and even within specific compartments of the
tissues. ORP3 isoforms (1a–1c) and (2a–2c) were highly ex-
pressed in whole brain tissue but negligible in the cerebellum.
Interestingly, in a study characterizing ORP2, the reverse ex-
pression pattern was found, with the highest expression in the
cerebellum and lower expression in the whole brain (Laitinen
et al., 2002). Of the exon 9/12 variations, the exon 12 deletion
was most common in the brain and an earlier cloning experi-
ment from hypothalamus confirmed this finding (data not
shown). Interestingly, the expression of the extended exon 15
isoforms that results in a putative shortened protein was quite
similar to the isoforms of the standard exon 15. The higher
mRNA expression previously reported in CD341 hematopoi-
etic cells compared with CD342, was seen in the extended exon
15 isoforms but not in the standard exon 15 group. This may
be due to the reduced sensitivity of semiquantitative RT-PCR
compared with real-time PCR technology (which was utilized
in the earlier study). In addition, the primers used in the real-
time experiments were designed within exon 23 at the end of
the coding region and would have amplified all the isoforms.
Their combined expression gave an overall greater expression
in CD341 hematopoietic cells, which is confirmed by this pres-
ent study.
It is difficult to compare previous ORP3 expression profiles
as the results depend on the position of the primers or probes.
In one ORP family study, the primers were designed out of the
coding region, and therefore, would have amplified all the re-
ported isoforms. The expression of OSBPL3 (5ORP3) was de-
scribed as quite low, but appeared to be present in pineal and
lung and ARPE-19 cells (retinal epithelium) (Jaworski et al.,
2001). More comprehensive data from a multiple expression
filter array (Lehto et al., 2001) found ORP3 expression high-
est in the kidney, small intestine, thymus, spleen, leukocytes,
and lung. Unfortunately, the size and position of the ORP3
probe used in the hybridization was not made clear, but aside
from the lung, the tissue distribution was similar to our results
for ORP3 (1a–d).
In conclusion, we have identified at least eight isoforms of
ORP3 with specific gene and tissue distribution. The theoreti-
cal translation of these isoforms result in a number of protein
sequences. Further studies are needed to investigate which of
these isoforms are expressed as proteins and what role they play
in the binding and regulation of the inhibitory effects of oxys-
terols, particularly in hematopoietic cells.
Note added in proof: Since the submission of this paper, an-
notation of the database by the NCBI resulted in these ORP3
isoforms also being designated OSBPL3, Variants 1–8.
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